Birmingham, West Midlands -- (SBWIRE) -- 10/10/2013 -- Value Penny Stocks issues special report on Sauer Energy Inc(OTCMKTS:SENY), Biozone Pharmaceuticals Inc(OTCBB:BZNE) , Puget Technologies Inc(OTCBB:PUGE) , TapImmune Inc.(OTCMKTS:TPIV)
Sauer Energy Inc(OTCMKTS:SENY) managed to keep its gain at 79.17% on above-normal volume of 2.26 million shares. The stock settled at $0.215 after floating in a range of $0.14 to $0.40. Its latest price was $0.215, reaching market capitalization of $19.88 million. Its 52-week range has been $0.08 to $0.40. Sauer Energy, Inc., a development stage company, engages in the design, development, manufacture, and distribution of vertical axis wind turbines (VAWT) for commercial and residential uses.
What was the Moving Force behind SENY On Bullish Run? Read This Research Report on SENY
Biozone Pharmaceuticals Inc(OTCBB:BZNE) traded down on a volume of 1.82 million, lower than its standard daily volume. Shares have dropped -16.11% to $0.453. Over the last twelve months, the stock has lost -72.12% and faced a worst price of $0.16. Biozone Pharmaceuticals, Inc., through its subsidiaries, engages in developing and manufacturing over the counter (OTC) drug products, and cosmetic and beauty products on behalf of third parties in the United States and internationally.
Has BZNE Found The Bottom And Ready To Gain Momentum? Find Out Here
Puget Technologies Inc(OTCBB:PUGE) settled -5.92% lower at $1.43 on above-normal volume of 260,297.00 shares during the last trading day. The stock has its 12-month high at $1.68 and 52-week low price was $0.01. It traded in a range of $1.40 to $1.58 during the last trading day. Puget Technologies, Inc., through its subsidiaries, develops and distributes energy drink products. The company offers B-29 carbonated beverage and energy shots. It is also involved in the identification, research, and development of cannabis (marijuana) derived medicinal products. Puget Technologies, Inc. was founded in 2010 and is headquartered in Fort Lauderdale, Florida.
Why Should Investors Buy PUGE After the Recent Fall ? Just Go Here and Find Out
TapImmune Inc.(OTCMKTS:TPIV) saw its price gain on above-normal volume, as 14.22 million shares changed hands when compared with its average daily volume of 807,303.00 shares. The stock was up 40.58% to $0.0097. It has fallen over the last 12 months, dropping -92.15% and marked new low $0.01. TapImmune Inc., a development stage company, engages in the discovery and development of immunotherapeutics for the treatment of cancer, as well as therapies for infectious diseases, autoimmune disorders, and transplant tissue rejection.
Why Should Investors Buy TPIV After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)